BioSpace News Archive

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced the pricing of its public offering of 10,166,666 shares of its common stock at a public offering price of $3.00 per share.

Each sample is identified by adding a unique index sequence to an NGS library, ensuring these libraries can be mixed and sequenced collectively.

Published today in Science, the research team from the Peter Doherty Institute for Infection and Immunity (Doherty Institute), the Olivia Newton-John Cancer Research Institute and CSL Limited say this breakthrough of discovering how gamma-delta T cells become activated addresses a question that has baffled scientists for 25 years.

January 13 to 15, 2020 in San Francisco concurrent with the JP Morgan 38th Annual Healthcare Conference, the world’s largest healthcare investment symposium

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that in 2019 it entered into agreements with nine new companies.

Sten R. Sörensen, will present at Biotech Showcase™ 2020 being held January 13-15, 2020 at the Hilton San Francisco Union Square.

Twinlab Consolidated Holdings, Inc. announced that it has successfully completed a long awaited ERP system upgrade, choosing Oracles NetSuite platform to help sustain its current growth trajectory into the future.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 fourth quarter and full-year financial results for Friday, January 31, 2020 before the market opens.

In October 2019, Rohnert Park Cancer Center (RPCC), South Sacramento Cancer Center (SSCC), and Fresno Cancer Center (FCC), all US Cancer Management Corporation (USCMC) Cancer Centers, earned national recognition for the quality of cancer care provided to California patients by receiving ASTRO’s APEx (Accreditation Program for Excellence) Accreditation.

New York-based health media company SurvivorNet has just closed a new round of funding, bringing its total outside investment to $15-million.